Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Yihao Biological Technology, also known as Yhaobio, is a life science enterprise based in Shanghai that provides integrated technical services and reagents for biological research and drug discovery. Founded in 2006, the company offers a comprehensive service portfolio including molecular biology, protein chemistry, cellular biology, and multi-omics analysis such as proteomics and next-generation sequencing (NGS). Yhaobio is particularly recognized for its specialized capabilities in stable cell line development, lentiviral and adenoviral vector packaging, and custom antibody production. The company serves a global client base including academic institutions, hospitals, and pharmaceutical companies, facilitating fundamental research and the early stages of drug development. By providing high-quality biological products and reliable technical support, Yihao enables researchers to streamline their experimental workflows and accelerate scientific discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Yihao Biological Technology.